In this week’s Kingscrowd Podcast, Brian Belley, Léa Bouhelier-Gautreau, and Teddy Lyons explore down rounds—funding rounds at reduced valuations—and their impact on investors. While commonly viewed negatively, down rounds can offer strategic investment opportunities when understood in context. They examine real-world examples, including Elemental Health, to explain how investors should approach these scenarios.
Next, the team reviews a compelling follow-up funding opportunity: Neopenda, a med-tech innovator that provides affordable, battery-powered health monitors for newborns in resource-limited hospitals. With EU regulatory approval secured, Neopenda’s device is positioned for significant global expansion, tackling critical healthcare challenges. The analysis covers valuation insights, founder motivations, risks, and potential returns.